Your browser doesn't support javascript.
loading
Diabetes medications and risk of HCC.
Plaz Torres, Maria Corina; Jaffe, Ariel; Perry, Rachel; Marabotto, Elisa; Strazzabosco, Mario; Giannini, Edoardo G.
Afiliação
  • Plaz Torres MC; Gastroenterology Unit, Department of Internal MedicineIRCCS-Ospedale Policlinico San Martino, University of GenoaGenoaItaly.
  • Jaffe A; Liver CenterDepartment of Internal MedicineYale University School of MedicineNew HavenConnecticutUSA.
  • Perry R; Liver CenterDepartment of Internal MedicineYale University School of MedicineNew HavenConnecticutUSA.
  • Marabotto E; Section of EndocrinologyDepartment of Internal MedicineYale University School of MedicineNew HavenConnecticutUSA.
  • Strazzabosco M; Department of Cellular and Molecular PhysiologyYale University School of MedicineNew HavenConnecticutUSA.
  • Giannini EG; Gastroenterology Unit, Department of Internal MedicineIRCCS-Ospedale Policlinico San Martino, University of GenoaGenoaItaly.
Hepatology ; 76(6): 1880-1897, 2022 12.
Article em En | MEDLINE | ID: mdl-35239194

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Diabetes Mellitus Tipo 2 / Neoplasias Hepáticas Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Diabetes Mellitus Tipo 2 / Neoplasias Hepáticas Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article